The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
LPA receptor signaling: pharmacology, physiology, and pathophysiology
Open accessAbstract
Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and nonvertebrate organisms that mediates diverse biological actions and demonstrates medicinal relevance. LPA's functional roles are driven by extracellular signaling through at least six 7-transmembrane G protein-coupled receptors. These receptors are named LPA1-6 and signal through numerous effector pathways activated by heterotrimeric G proteins, including Gi/o, G12/13, Gq, and Gs LPA receptor-mediated effects have been described in numerous cell types and model systems, both in vitro and in vivo, through gain- and loss-of-function studies. These studies have revealed physiological and pathophysiological influences on virtually every organ system and developmental stage of an organism. These include the nervous, cardiovascular, reproductive, and pulmonary systems. Disturbances in normal LPA signaling may contribute to a range of diseases, including neurodevelopmental and neuropsychiatric disorders, pain, cardiovascular disease, bone disorders, fibrosis, cancer, infertility, and obesity. These studies underscore the potential of LPA receptor subtypes and related signaling mechanisms to provide novel therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–264 of 264
Shinkuma, S., Akiyama, M., Inoue, A., Aoki, J., Natsuga, K., Nomura, T., Arita, K., Abe, R., Ito, K., Nakamura, H., et al. (2010) · Human Mutation · doi:10.1002/humu.21235 · Cited by 57
Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis
Cho, W. H., Park, T., Park, Y.-Y., Huh, J. W., Lim, C., Koh, Y., Song, D., & Hong, S.-B. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1505-6 · Cited by 57
Tabuchi, S., Kume, K., Aihara, M., & Shimizu, T. (2000) · Neurochemical Research · doi:10.1023/a:1007542532395 · Cited by 56
The emerging role of lysophosphatidic acid (LPA) in skeletal biology
Blackburn, J., & Mansell, J. P. (2011) · Bone · doi:10.1016/j.bone.2011.12.002 · Cited by 56
Lysophosphatidic acid: A potential mediator of osteoblast–osteoclast signaling in bone
Sims, S. M., Panupinthu, N., Lapierre, D. M., Pereverzev, A., & Dixon, S. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.001 · Cited by 56
Emo, J. A., Meednu, N., Chapman, T. J., Rezaee, F., Balys, M. M., Randall, T. D., Rangasamy, T., & Georas, S. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102956 · Cited by 56
Lysophospholipids in development: Miles apart and edging in
Saba, J. D. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20128 · Cited by 56
Komachi, M., Sato, K., Tobo, M., Mogi, C., Yamada, T., Ohta, H., Tomura, H., Kimura, T., Im, D., Yanagida, K., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02246.x · Cited by 55
Lee, S., Leoni, G., Neumann, P., Chun, J. J. M., Nusrat, A., & Yun, C. C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00038-13 · Cited by 55
Self-citationDawson, J. C., Hotchin, N. A., Lax, S., & Rumsby, M. G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02056.x · Cited by 54
Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake
Yea, K., Kim, J. J., Lim, S., Park, H. S., Park, K. S., Suh, P., & Ryu, S. H. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0269-z · Cited by 54
Pedraza, C., Sánchez-López, J., Castilla‐Ortega, E., Rosell‐Valle, C., Zambrana-Infantes, E. N., Garcia‐Fernandez, M. I., de Fonseca, F. R., Chun, J. J. M., Santín, L. J., & Estivill‐Torrús, G. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0592-9 · Cited by 53
Self-citationLysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells
Rubenfeld, J., Guo, J., Sookrung, N., Chen, R., Chaicumpa, W., Casolaro, V., Zhao, Y., Natarajan, V., & Georas, S. N. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00473.2004 · Cited by 53
Colorectal cancer cells – Proliferation, survival and invasion by lysophosphatidic acid
Lee, S., & Yun, C. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.09.021 · Cited by 53
Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis
Orosa‐Puente, B., García, S., Martínez, P., Gonzalez, A., Gómez-Reino, J. J., & Conde, C. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202832 · Cited by 53
Diversity of LPA receptor-mediated intracellular calcium signaling in early cortical neurogenesis
Dubin, A. E., Herr, D., & Chun, J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6151-09.2010 · Cited by 52
Self-citationMasuda, A., Fujii, T., Iwasawa, Y., Nakamura, K., Ohkawa, R., Igarashi, K., Okudaira, S., Ikeda, H., Kōzuma, S., Aoki, J., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.039 · Cited by 52
Lundequist, A., & Boyce, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018192 · Cited by 51
Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome
Dohi, T., Miyauchi, K., Ohkawa, R., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.09.027 · Cited by 51
Zeng, Y., Kakehi, Y., Nouh, M. A. A. M., Tsunemori, H., Sugimoto, M., & Wu, X. (2008) · The Prostate · doi:10.1002/pros.20879 · Cited by 49
Nogaroli, L., Yuelling, L. M., Dennis, J., Gorse, K. M., Payne, S. G., & Fuss, B. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9772-z · Cited by 49
A functional SNP in EDG2 increases susceptibility to knee osteoarthritis in Japanese
Mototani, H., Iida, A., Nakajima, M., Furuichi, T., Miyamoto, Y., Tsunoda, T., Sudo, A., Kotani, A., Uchida, A., Ozaki, K., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn069 · Cited by 49
Spohr, T. C. L. D. S. E., Dezonne, R. S., Rehen, S. K., & Gomes, F. C. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07421.x · Cited by 48
Stankoff, B., Barron, S., Allard, J., Barbin, G., Noël, F., Aigrot, M. S., Premont, J., Sokoloff, P., Zalc, B., & Lubetzki, C. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1129 · Cited by 48
Tamaruya, Y., Suzuki, M., Kamura, G., Kanai, M., Hama, K., Shimizu, K., Aoki, J., Arai, H., & Shibasaki, M. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200454065 · Cited by 47
Iwasawa, Y., Fujii, T., Nagamatsu, T., Kawana, K., Okudaira, S., Miura, S., Matsumoto, J., Tomio, A., Hyodo, H., Yamashita, T., et al. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00715.x · Cited by 46
Im, D. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.135 · Cited by 46
Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors
Obo, Y., Yamada, T., Furukawa, M., Hotta, M., Honoki, K., Fukushima, N., & Tsujiuchi, T. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.10.005 · Cited by 45
A neonatal piglet model of intraventricular hemorrhage and posthemorrhagic ventricular dilation
Aquilina, K., Hobbs, C., Cherian, S., Tucker, A. M., Porter, H. J., Whitelaw, A. C., & Thoresen, M. (2007) · Journal of Neurosurgery Pediatrics · doi:10.3171/ped-07/08/126 · Cited by 45
Svetlov, S. I., Ignatova, T. N., Wang, K., Hayes, R. L., English, D. K., & Kukekov, V. G. (2004) · Stem Cells and Development · doi:10.1089/scd.2004.13.685 · Cited by 43
Dutta, S., Wang, F., Wu, H., Mukherjee, T. J., & Fishman, D. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.006 · Cited by 42
Immunohistological localization of the myelinating cell‐specific receptor LPA1
Cervera, P., Tirard, M., Barrón, S., Allard, J., Trottier, S., Lacombe, J., Daumas‐Duport, C., & Sokoloff, P. (2002) · Glia · doi:10.1002/glia.10054 · Cited by 41
Musazzi, L., Daniel, E. D., Maycox, P. R., Racagni, G., & Popoli, M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001240 · Cited by 41
Rhee, H. J., Nam, J., Sun, Y., Kim, M., Choi, H., Han, D.-H., Kim, N., & Huh, S. (2006) · Neuroreport · doi:10.1097/01.wnr.0000209011.16718.68 · Cited by 40
Li, Z., Yu, Z.-C., Wang, D.-Z., Ju, W., Zhan, X., Wu, Q., Wu, X., Cong, H., & Man, H.-H. (2008) · Neurological Research · doi:10.1179/174313208x300369 · Cited by 39
Regulation Of Angiogenesis By Phospholipid Lysophosphatidic Acid
Ren, B. (2013) · Frontiers in bioscience · doi:10.2741/4148 · Cited by 39
Varsano, T., Taupin, V., Guo, L., Baterina, O. Y., & Farquhar, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049227 · Cited by 39
Wocławek-Potocka, I., Kondraciuk, K., & Skarzynski, D. J. (2009) · Experimental Biology and Medicine · doi:10.3181/0901-rm-36 · Cited by 38
Chang, C., Hsu, H., Lin, H., Chiang, W., & Lee, H. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.05.002 · Cited by 38
Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells
Holtsberg, F. W., Steiner, M. R., Bruce‐Keller, A. J., Keller, J. N., Mattson, M. P., Moyers, J. C., & Steiner, S. M. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980915)53:6<685::aid-jnr7>3.0.co;2-1 · Cited by 38
PTPL1/FAP-1 Negatively Regulates TRIP6 Function in Lysophosphatidic Acid-induced Cell Migration
Lai, Y., Lin, W.-C., & Lin, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701499200 · Cited by 37
Lysophosphatidic Acid Induction of Neuronal Apoptosis and Necrosis
Steiner, M. R., Holtsberg, F. W., Keller, J. N., Mattson, M. P., & Steiner, S. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06545.x · Cited by 35
Lysophosphatidic Acid Modulates the Activation of Human Monocyte-Derived Dendritic Cells
Chen, R., Roman, J. A., Guo, J., West, E. E., McDyer, J. F., Williams, M. A., & Georas, S. N. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.797 · Cited by 33
Mansell, J. P., Barbour, M. E., Moore, C., Nowghani, M., Pabbruwe, M. B., Sjöström, T., & Blom, A. W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.035 · Cited by 31
Aaltonen, N., Laitinen, J. T., & Lehtonen, M. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.03.030 · Cited by 30
Koike, S., Keino‐Masu, K., & Masu, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.008 · Cited by 30
Lysophospholipid Receptors: Signaling and Biochemistry
Chun, J. J. M. (2013) · Cited by 29
Self-citationLiszewska, E., Reinaud, P., Dubois, O., et al. (2011) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2011.08.003 · Cited by 29
Lloyd, R. B., Tao, Q., Tanadini‐Lang, S., & Wylie, C. (2005) · Development · doi:10.1242/dev.01618 · Cited by 27
Furukawa, A., Kita, K., Toyomoto, M., Fujii, S., Inoue, S., Hayashi, K., & Ikeda, K. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9524-4 · Cited by 26
EDG receptors as a potential therapeutic target in retinal ischemia–reperfusion injury
Savitz, S. I., Dhallu, M. S., Malhotra, S., Mammis, A., Ocava, L., Rosenbaum, P. S., & Rosenbaum, D. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.060 · Cited by 22
Holmström, T. E., Mattsson, C. L., Wang, Y., Iakovleva, I., Petrovič, N., & Nedergaard, J. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.029 · Cited by 21
Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts
Yin, Z., Carbone, L. D., Gotoh, M., Postlethwaite, A. E., Bolen, A. L., Tigyi, G., Murakami‐Murofushi, K., & Watsky, M. A. (2010) · Rheumatology · doi:10.1093/rheumatology/keq260 · Cited by 21
Nobusue, H., Kondo, D., Yamamoto, M., & Kano, K. (2010) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2010.08.010 · Cited by 19
Aaltonen, N., Lehtonen, M., Varonen, K., Goterris, G. A., & Laitinen, J. T. (2012) · BMC Pharmacology · doi:10.1186/1471-2210-12-7 · Cited by 19
Systematic generation of in vivo G protein-coupled receptor mutants in the rat
van Boxtel, R., Vroling, B., Toonen, P. W., Nijman, I. J., van Roekel, H. S., Verheul, M., Baakman, C. A. B., Guryev, V., Vriend, G., & Cuppen, E. P. J. G. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.44 · Cited by 18
Dual action of lysophosphatidic acid in cultured cortical neurons: survival and apoptogenic.
Zheng, Z., Fang, X., & Qiao, J. (2004) · PubMed · Cited by 18
Sato, K., Horiuchi, Y., Ye, J., Malchinkhuu, E., Komachi, M., Kondo, T., & Okajima, F. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07188.x · Cited by 17
Targeting the epithelial cells in fibrosis: a new concept for an old disease
Moll, S., Chaykovska, L., Meier, M., Budd, D. C., Formentini, I., Pomposiello, S. I., & Prunotto, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.006 · Cited by 12
Biologically active phospholipids as potential cardiovascular drugs
Blankley, C. J., & KAPLAN, H. R. (1984) · Drug Development Research · doi:10.1002/ddr.430040310 · Cited by 7
Lysophosphatidic Acid (LPA) Receptor Signaling
Mirendil, H., Lin, M., & Chun, J. J. M. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch1 · Cited by 6
Self-citationMorishige, J., Uto, Y., Hori, H., et al. (2013) · Lipids · doi:10.1007/s11745-013-3765-7 · Cited by 4
Clinical Introduction of Lysophosphatidic Acid (LPA) and Autotaxin Assays
Yatomi, Y., Igarashi, K., Nakamura, K., Ohkawa, R., Masuda, A., Suzuki, A., Kishimoto, T., Ikeda, H., & Aoki, J. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch33 · Cited by 2
LPA Receptor Subtypes LPA 1 and LPA 2 as Potential Drug Targets
Bain, G., & Seiders, T. J. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch32 · Cited by 1
Cited by
Ferroptosis as a novel therapeutic target for cardiovascular disease
Wu, X., Li, Y., Zhang, S., & Zhou, X. (2021) · Theranostics · doi:10.7150/thno.54113 · Cited by 647
Lipids in the tumor microenvironment: From cancer progression to treatment
Corn, K. C., Windham, M. A., & Rafat, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101055 · Cited by 469
Emerging roles of lysophospholipids in health and disease
Tan, S. T., Ramesh, T., Toh, X. R., & Nguyen, L. N. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101068 · Cited by 371
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Metadata
- Authors
- Yung, Y. C., Stoddard, N. C., & Chun, J.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 55
- Issue
- 7
- Pages
- 1192-1214
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2108812575
- Cited by
- 710
- References
- 264
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.